Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Darren Charlton Smith currently holds 13,992 shares of Telix Pharmaceuticals Ltd (TLX), valued at approximately $0. This represents their equity stake as Group Chief Financial Officer.
Based on SEC Form 4 filings, Darren Charlton Smith has been a net buyer of TLX stock. They have purchased $20.0K and sold $0 worth of shares.
Darren Charlton Smith's most recent insider trade was on Sep 7, 2026, when they purchased 2,071 shares at $9.66 per share.
Darren Charlton Smith serves as Group Chief Financial Officer at Telix Pharmaceuticals Ltd (TLX). They have executed 3 insider transactions totaling $20.0K over their tenure at the company.
Darren Charlton Smith holds the position of Group Chief Financial Officer at Telix Pharmaceuticals Ltd, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Darren Charlton Smith has shown a buying trading pattern, with $20.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Darren Charlton Smith was on Sep 7, 2026, when they purchased $20.0K worth of TLX shares. This transaction involved 2,071 shares at $9.66 per share.
Darren Charlton Smith currently owns 13,992 shares of Telix Pharmaceuticals Ltd (TLX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Darren Charlton Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Darren Charlton Smith has 3 Form 4 filings on record as an insider at Telix Pharmaceuticals Ltd.
Set alerts for Darren Charlton Smith and 40,000+ other insiders.